TRIB
Income statement / Annual
Last year (2025), Trinity Biotech Plc's total revenue was $43.79 M,
a decrease of 28.87% from the previous year.
In 2025, Trinity Biotech Plc's net income was -$37.38 M.
See Trinity Biotech Plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$43.79 M |
$61.56 M |
$56.83 M |
$62.52 M |
$81.15 M |
$101.98 M |
$90.44 M |
$97.04 M |
$99.14 M |
$99.61 M |
| Cost of Revenue |
$26.90 M
|
$40.11 M
|
$37.38 M
|
$52.73 M
|
$54.89 M
|
$53.40 M
|
$52.32 M
|
$55.59 M
|
$57.25 M
|
$56.52 M
|
| Gross Profit |
$16.89 M
|
$21.44 M
|
$19.45 M
|
$22.05 M
|
$33.45 M
|
$48.58 M
|
$38.12 M
|
$41.45 M
|
$41.89 M
|
$43.09 M
|
| Gross Profit Ratio |
0.39
|
0.35
|
0.34
|
0.35
|
0.41
|
0.48
|
0.42
|
0.43
|
0.42
|
0.43
|
| Research and Development Expenses |
$3.63 M
|
$4.54 M
|
$4.38 M
|
$4.14 M
|
$4.50 M
|
$5.08 M
|
$5.33 M
|
$5.37 M
|
$5.66 M
|
$5.04 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$24.68 M
|
$25.07 M
|
$27.58 M
|
$29.50 M
|
$30.85 M
|
$30.80 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$24.67 M
|
$28.82 M
|
$31.15 M
|
$29.17 M
|
$24.68 M
|
$25.07 M
|
$27.58 M
|
$29.50 M
|
$30.85 M
|
$30.80 M
|
| Other Expenses |
$0.00
|
$9.25 M
|
$10.96 M
|
-$343.00 K
|
$336.00 K
|
$18.34 M
|
-$91.00 K
|
-$102.00 K
|
-$100.00 K
|
$0.00
|
| Operating Expenses |
$28.30 M
|
$42.61 M
|
$46.50 M
|
$32.96 M
|
$29.52 M
|
$48.50 M
|
$32.82 M
|
$34.77 M
|
$36.41 M
|
$35.60 M
|
| Cost And Expenses |
$55.20 M
|
$82.72 M
|
$83.88 M
|
$81.87 M
|
$77.21 M
|
$101.90 M
|
$85.13 M
|
$90.35 M
|
$93.66 M
|
$92.12 M
|
| Interest Income |
$221.00 K
|
$0.00
|
$1.17 M
|
$303.00 K
|
$1.22 M
|
$36.00 K
|
$464.00 K
|
$2.12 M
|
$808.00 K
|
$2.43 M
|
| Interest Expense |
$13.11 M
|
$9.57 M
|
$10.15 M
|
$24.73 M
|
$7.10 M
|
$6.75 M
|
$5.58 M
|
$5.08 M
|
$5.41 M
|
$4.73 M
|
| Depreciation & Amortization |
$2.68 M
|
$1.87 M
|
$1.78 M
|
$2.33 M
|
$2.74 M
|
$3.08 M
|
$4.89 M
|
$4.12 M
|
$5.20 M
|
$5.82 M
|
| EBITDA |
-$21.38 M |
-$16.91 M |
-$24.10 M |
-$16.71 M |
$10.59 M |
$3.20 M |
-$19.52 M |
-$13.98 M |
-$29.27 M |
-$30.92 M |
| EBITDA Ratio |
-0.49
|
-0.27
|
-0.42
|
-0.27
|
0.13
|
0.03
|
-0.22
|
-0.14
|
-0.3
|
-0.31
|
| Operating Income Ratio |
-0.26
|
-0.34
|
-0.48
|
-0.24
|
0.05
|
0
|
0.01
|
0.03
|
0.06
|
0.08
|
| Total Other Income/Expenses Net |
-$25.76 M
|
-$9.57 M
|
-$9.88 M
|
-$24.43 M
|
-$5.86 M
|
-$6.72 M
|
-$5.89 M
|
-$2.96 M
|
-$2.21 M
|
-$2.26 M
|
| Income Before Tax |
-$37.18 M
|
-$30.73 M
|
-$36.93 M
|
-$43.78 M
|
-$1.92 M
|
-$6.63 M
|
$821.00 K
|
$3.03 M
|
$1.60 M
|
$5.19 M
|
| Income Before Tax Ratio |
-0.85
|
-0.5
|
-0.65
|
-0.7
|
-0.02
|
-0.07
|
0.01
|
0.03
|
0.02
|
0.05
|
| Income Tax Expense |
$199.00 K
|
$486.00 K
|
-$59.00 K
|
-$194.00 K
|
-$74.00 K
|
-$620.00 K
|
$4.89 M
|
$637.00 K
|
-$697.00 K
|
$41.00 K
|
| Net Income |
-$37.38 M
|
-$31.79 M
|
-$24.02 M
|
-$41.00 M
|
$875.00 K
|
-$6.39 M
|
-$4.07 M
|
$2.39 M
|
-$40.27 M
|
-$100.63 M
|
| Net Income Ratio |
-0.85
|
-0.52
|
-0.42
|
-0.66
|
0.01
|
-0.06
|
-0.04
|
0.02
|
-0.41
|
-1.01
|
| EPS |
-60 |
-52.98 |
-96 |
-180 |
6.3 |
-46.14 |
-29.1 |
17.1 |
-279.3 |
-657.3 |
| EPS Diluted |
-60 |
-52.98 |
-96 |
-156 |
4.92 |
-46.14 |
-24 |
13.8 |
-224.7 |
-533.4 |
| Weighted Average Shares Out |
$619.19 K
|
$598.65 K
|
$255.17 K
|
$224.90 K
|
$139.34 K
|
$139.34 K
|
$139.34 K
|
$139.35 K
|
$144.14 K
|
$153.10 K
|
| Weighted Average Shares Out Diluted |
$619.19 K
|
$598.65 K
|
$255.17 K
|
$259.16 K
|
$177.53 K
|
$139.34 K
|
$169.78 K
|
$172.51 K
|
$179.18 K
|
$188.66 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
